Related Experiment Video
Updated: Jun 12, 2026
06:11
Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection
Published on: May 17, 2024
Gestational diabetes mellitus screening based on the gene chip technique
Zhaoxia Liang1, Minyue Dong, Qi Cheng
1Obstetrical Department, Women's Hospital, School of Medicine, Zhejiang University, Xueshi Rd #1, Hangzhou 310006, China. liangzhaoxia@sohu.com
Diabetes Research and Clinical Practice
|June 18, 2010
Summary
This study validates gene chip technology for screening gestational diabetes mellitus (GDM). The method successfully identified specific genetic markers, demonstrating its feasibility for GDM detection in pregnant women.
Area of Science:
- Genetics
- Reproductive Medicine
- Biotechnology
Background:
- Gestational diabetes mellitus (GDM) poses risks to maternal and fetal health.
- Accurate and efficient screening methods for GDM are crucial for timely intervention.
- Single-nucleotide polymorphisms (SNPs) are increasingly recognized for their role in complex diseases like GDM.
Purpose of the Study:
- To validate the efficacy of gene chip technology for screening gestational diabetes mellitus (GDM).
- To identify specific genetic markers associated with GDM susceptibility.
- To establish a reliable diagnostic tool for GDM.
Main Methods:
- Genotyping of 70 diabetes-associated SNPs in 130 participants (50 GDM cases, 80 controls).
- Development and design of gene chips based on statistically analyzed SNP patterns.
- Analysis of peripheral blood samples from 48 pregnant women (24 GDM, 24 healthy) using the gene chip method.
- Verification of gene chip results through DNA sequencing.
Main Results:
- Four candidate SNPs (rs13266634, rs266729, rs3802177, rs9300039) were identified.
- Gene chips met quality standards, with primers designed for the selected SNPs.
- Significant genotype differences were observed for SNPs rs3802177, rs13266634, and rs266729 between GDM and healthy pregnant women.
- Gene chip results were consistent with DNA sequencing validation.
Conclusions:
- The gene chip technique is a feasible and effective method for screening gestational diabetes mellitus.
- Candidate SNPs (rs3802177, rs13266634, rs266729) show potential as biomarkers for GDM.
- This study provides a foundation for further research into genetic loci associated with GDM.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...